Is Alterity Therapeutics Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: ATHE) stock is to Strong Buy ATHE stock.
Out of 3 analysts, 2 (66.67%) are recommending ATHE as a Strong Buy, 1 (33.33%) are recommending ATHE as a Buy, 0 (0%) are recommending ATHE as a Hold, 0 (0%) are recommending ATHE as a Sell, and 0 (0%) are recommending ATHE as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year ATHE price target, the average ATHE price target is $12.67, with the highest ATHE stock price forecast at $16.00 and the lowest ATHE stock price forecast at $10.00.
On average, Wall Street analysts predict that Alterity Therapeutics's share price could reach $12.67 by Aug 11, 2027. The average Alterity Therapeutics stock price prediction forecasts a potential upside of 171.24% from the current ATHE share price of $4.67.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.